{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:14:29Z","timestamp":1790997269477,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Investigator-Initiated Clinical Research Fund Project of The First Affiliated Hospital of Xiamen University","award":["XMFHIIT-2023SL060"],"award-info":[{"award-number":["XMFHIIT-2023SL060"]}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2021YFA1101500"],"award-info":[{"award-number":["2021YFA1101500"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-026-05033-1","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T09:31:57Z","timestamp":1777195917000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Lyophilized mesenchymal stromal cell-derived extracellular vesicles for the oral treatment of inflammatory bowel disease: a novel cell-free therapeutic strategy"],"prefix":"10.1186","volume":"17","author":[{"given":"Shuangshuang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenya","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taijie","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,26]]},"reference":[{"key":"5033_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.pop.2023.03.009","volume":"50","author":"LP Bruner","year":"2023","unstructured":"Bruner LP, White AM, Proksell S. Inflammatory bowel disease. Prim Care. 2023;50:411\u201327.","journal-title":"Prim Care"},{"key":"5033_CR2","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41586-025-08940-0","volume":"642","author":"L Hracs","year":"2025","unstructured":"Hracs L, Windsor JW, Gorospe J, Cummings M, Coward S, Buie MJ, et al. Global evolution of inflammatory bowel disease across epidemiologic stages. Nature. 2025;642:458\u201366.","journal-title":"Nature"},{"key":"5033_CR3","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.1136\/gutjnl-2024-334395","volume":"74","author":"GW Moran","year":"2025","unstructured":"Moran GW, Gordon M, Sinopolou V, Radford SJ, Darie A-M, Vuyyuru SK, et al. British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025. Gut. 2025;74:s1\u2013101.","journal-title":"Gut"},{"key":"5033_CR4","doi-asserted-by":"publisher","first-page":"e000853","DOI":"10.1136\/bmjgast-2021-000853","volume":"9","author":"E Louis","year":"2022","unstructured":"Louis E, Paridaens K, Al Awadhi S, Begun J, Cheon JH, Dignass AU, et al. Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis. BMJ Open Gastroenterol. 2022;9:e000853.","journal-title":"BMJ Open Gastroenterol"},{"key":"5033_CR5","doi-asserted-by":"publisher","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","volume":"114","author":"DT Rubin","year":"2019","unstructured":"Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG clinical guideline: ulcerative colitis in adults. Off J Am Coll Gastroenterol. 2019;114:384\u2013413.","journal-title":"Off J Am Coll Gastroenterol"},{"key":"5033_CR6","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/ecco-jcc\/jjad013","volume":"17","author":"M Simsek","year":"2023","unstructured":"Simsek M, Schepers F, Kaplan S, Van Asseldonk D, Van Boeckel P, Boekema P, et al. Thioguanine is effective as maintenance therapy for inflammatory bowel disease: a prospective multicentre registry study. J Crohns Colitis. 2023;17:933\u201342.","journal-title":"J Crohns Colitis"},{"key":"5033_CR7","doi-asserted-by":"publisher","first-page":"4245704","DOI":"10.1155\/2023\/4245704","volume":"2023","author":"CM Tian","year":"2023","unstructured":"Tian CM, Yang MF, Xu HM, Zhu MZ, Zhang Y, Yao J, et al. Mesenchymal stem cell-derived exosomes: Novel therapeutic approach for inflammatory bowel diseases. Stem Cells Int. 2023;2023:4245704.","journal-title":"Stem Cells Int"},{"key":"5033_CR8","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s00384-022-04190-y","volume":"37","author":"K Jiang","year":"2022","unstructured":"Jiang K, Chen BS, Lou DD, Zhang MT, Shi YT, Dai W, et al. Systematic review and meta-analysis: association between obesity\/overweight and surgical complications in IBD. Int J Colorectal Dis. 2022;37:1485\u201396.","journal-title":"Int J Colorectal Dis"},{"key":"5033_CR9","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1111\/codi.15744","volume":"23","author":"RK Grant","year":"2021","unstructured":"Grant RK, Elosua-Gonz\u00e1lez A, Bouri S, Sahnan K, Brindle WM, Dilke SM, et al. Prognostic factors associated with unhealed perineal wounds post\u2010proctectomy for perianal Crohn\u2019s disease: a two\u2010centre study. Colorectal Dis. 2021;23:2091\u20139.","journal-title":"Colorectal Dis"},{"key":"5033_CR10","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s12015-022-10369-1","volume":"18","author":"D Jovic","year":"2022","unstructured":"Jovic D, Yu Y, Wang D, Wang K, Li H, Xu F, et al. A brief overview of global trends in MSC-based cell therapy. Stem Cell Rev Rep. 2022;18:1525\u201345.","journal-title":"Stem Cell Rev Rep"},{"key":"5033_CR11","doi-asserted-by":"publisher","first-page":"16040","DOI":"10.3390\/ijms242216040","volume":"24","author":"LN Zaripova","year":"2023","unstructured":"Zaripova LN, Midgley A, Christmas SE, Beresford MW, Pain C, Baildam EM, et al. Mesenchymal stem cells in the pathogenesis and therapy of autoimmune and autoinflammatory diseases. Int J Mol Sci. 2023;24:16040.","journal-title":"Int J Mol Sci"},{"key":"5033_CR12","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.3390\/ph16091334","volume":"16","author":"LE Fern\u00e1ndez-Garza","year":"2023","unstructured":"Fern\u00e1ndez-Garza LE, Barrera-Barrera SA, Barrera-Salda\u00f1a HA. Mesenchymal stem cell therapies approved by regulatory agencies around the world. Pharmaceuticals. 2023;16:1334.","journal-title":"Pharmaceuticals"},{"key":"5033_CR13","unstructured":"US Food and Drug Administration. FDA approves first mesenchymal stromal cell therapy to treat steroid-refractory acute graft-versus-host disease. Silver Spring (MD): FDA. 2024. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-mesenchymal-stromal-cell-therapy-treat-steroid-refractory-acute-graft-versus-host"},{"key":"5033_CR14","volume-title":"The National Medical Products Administration conditionally approved the marketing of emmetocel injection","author":"National Medical Products Administration","year":"2025","unstructured":"National Medical Products Administration. The National Medical Products Administration conditionally approved the marketing of emmetocel injection. Beijing: NMPA; 2025. https:\/\/www.nmpa.gov.cn\/zhuanti\/cxylqx\/cxypxx\/20250102192741146.html."},{"key":"5033_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315\u20137.","journal-title":"Cytotherapy"},{"key":"5033_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s41232-017-0045-6","volume":"37","author":"A Tsuchiya","year":"2017","unstructured":"Tsuchiya A, Kojima Y, Ikarashi S, Seino S, Watanabe Y, Kawata Y, et al. Clinical trials using mesenchymal stem cells in liver diseases and inflammatory bowel diseases. Inflamm Regen. 2017;37:16.","journal-title":"Inflamm Regen"},{"key":"5033_CR17","doi-asserted-by":"publisher","first-page":"8905","DOI":"10.3390\/ijms23168905","volume":"23","author":"N Eiro","year":"2022","unstructured":"Eiro N, Fraile M, Gonz\u00e1lez-Jubete A, Gonz\u00e1lez LO, Vizoso FJ. Mesenchymal (stem) stromal cells based as new therapeutic alternative in inflammatory bowel disease: basic mechanisms, experimental and clinical evidence, and challenges. Int J Mol Sci. 2022;23:8905.","journal-title":"Int J Mol Sci"},{"key":"5033_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41392-023-01704-0","volume":"9","author":"F Tan","year":"2024","unstructured":"Tan F, Li X, Wang Z, Li J, Shahzad K, Zheng J. Clinical applications of stem cell-derived exosomes. Signal Transduct Target Ther. 2024;9:17.","journal-title":"Signal Transduct Target Ther"},{"key":"5033_CR19","doi-asserted-by":"crossref","unstructured":"Wang S, Lei B, Zhang E, Gong P, Gu J, He L et al. Targeted therapy for inflammatory diseases with mesenchymal stem cells and their derived exosomes: from basic to clinics. Int J Nanomed. 2022;1757\u201381.","DOI":"10.2147\/IJN.S355366"},{"key":"5033_CR20","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1080\/10717544.2021.1951896","volume":"28","author":"FM Yuan","year":"2021","unstructured":"Yuan FM, Li YM, Wang ZH. Preserving extracellular vesicles for biomedical applications: consideration of storage stability before and after isolation. Drug Deliv. 2021;28:1501\u20139.","journal-title":"Drug Deliv"},{"key":"5033_CR21","doi-asserted-by":"publisher","first-page":"e70009","DOI":"10.1002\/jex2.70009","volume":"3","author":"L Lu","year":"2024","unstructured":"Lu L, Han C, Wang M, Du H, Chen N, Gao M, et al. Assessment of bovine milk exosome preparation and lyophilized powder stability. J Extracell Biol. 2024;3:e70009.","journal-title":"J Extracell Biol"},{"key":"5033_CR22","doi-asserted-by":"publisher","first-page":"753","DOI":"10.2217\/nnm-2018-0240","volume":"14","author":"E Bari","year":"2019","unstructured":"Bari E, Perteghella S, Catenacci L, Sorlini M, Croce S, Mantelli M, et al. Freeze-dried and GMP-compliant pharmaceuticals containing exosomes for acellular mesenchymal stromal cell immunomodulant therapy. Nanomedicine. 2019;14:753\u201365.","journal-title":"Nanomedicine"},{"key":"5033_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2018.10.032","volume":"553","author":"C Charoenviriyakul","year":"2018","unstructured":"Charoenviriyakul C, Takahashi Y, Nishikawa M, Takakura Y. Preservation of exosomes at room temperature using lyophilization. Int J Pharm. 2018;553:1\u20137.","journal-title":"Int J Pharm"},{"key":"5033_CR24","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/cells7110190","volume":"7","author":"E Bari","year":"2018","unstructured":"Bari E, Perteghella S, Di Silvestre D, Sorlini M, Catenacci L, Sorrenti M, et al. Pilot production of mesenchymal stem\/stromal freeze-dried secretome for cell-free regenerative nanomedicine: a validated GMP-compliant process. Cells. 2018;7:190.","journal-title":"Cells"},{"key":"5033_CR25","doi-asserted-by":"publisher","first-page":"2201105","DOI":"10.1002\/adhm.202201105","volume":"11","author":"J Gan","year":"2022","unstructured":"Gan J, Sun L, Chen G, Ma W, Zhao Y, Sun L. Mesenchymal stem cell exosomes encapsulated oral microcapsules for acute colitis treatment. Adv Healthc Mater. 2022;11:2201105.","journal-title":"Adv Healthc Mater"},{"key":"5033_CR26","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/s41565-024-01681-7","volume":"19","author":"Z Wu","year":"2024","unstructured":"Wu Z, Chen L, Guo W, Wang J, Ni H, Liu J, et al. Oral mitochondrial transplantation using nanomotors to treat ischaemic heart disease. Nat Nanotechnol. 2024;19:1375\u201385.","journal-title":"Nat Nanotechnol"},{"key":"5033_CR27","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41575-025-01038-y","volume":"22","author":"DM Tshikudi","year":"2025","unstructured":"Tshikudi DM, Bernstein CN, Mishra S, Ghia J-E, Armstrong HK. Influence of biological sex in inflammatory bowel diseases. Nat Rev Gastroenterol Hepatol. 2025;22:415\u201337.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5033_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-1-4939-3139-2_12","volume-title":"Suppression and Regulation of Immune Responses: Methods and Protocols, Volume II","author":"JC Martin","year":"2016","unstructured":"Martin JC, B\u00e9riou G, Josien R. Dextran sulfate sodium (DSS)-induced acute colitis in the rat. In: Cuturi M, Anegon I, editors. Suppression and Regulation of Immune Responses: Methods and Protocols, Volume II. New York, NY: Humana; 2016. pp. 197\u2013203."},{"key":"5033_CR29","doi-asserted-by":"publisher","first-page":"105694","DOI":"10.1016\/j.phrs.2021.105694","volume":"170","author":"Q Li","year":"2021","unstructured":"Li Q, Cui Y, Xu B, Wang Y, Lv F, Li Z, et al. Main active components of Jiawei Gegen Qinlian decoction protects against ulcerative colitis under different dietary environments in a gut microbiota-dependent manner. Pharmacol Res. 2021;170:105694.","journal-title":"Pharmacol Res"},{"key":"5033_CR30","first-page":"238","volume":"9","author":"P Adamkova","year":"2022","unstructured":"Adamkova P, Hradicka P, Kupcova Skalnikova H, Cizkova V, Vodicka P, Farkasova Iannaccone S, et al. Dextran sulphate sodium acute colitis rat model: A suitable tool for advancing our understanding of immune and microbial mechanisms in the pathogenesis of inflammatory bowel disease. Vet Sci. 2022;9:238.","journal-title":"Vet Sci"},{"key":"5033_CR31","doi-asserted-by":"publisher","first-page":"5543003","DOI":"10.1155\/2021\/5543003","volume":"2021","author":"Q Xu","year":"2021","unstructured":"Xu Q, Hu M, Li M, Hou J, Zhang X, Gao Y, et al. Dietary bioactive peptide alanyl-glutamine attenuates dextran sodium sulfate\u2010induced colitis by modulating gut microbiota. Oxid Med Cell Longev. 2021;2021:5543003.","journal-title":"Oxid Med Cell Longev"},{"key":"5033_CR32","doi-asserted-by":"crossref","unstructured":"Ghosh I, Gutka H, Krause ME, Clemens R, Kashi RS. A systematic review of commercial high concentration antibody drug products approved in the US: formulation composition, dosage form design and primary packaging considerations. MAbs 15:2205540.","DOI":"10.1080\/19420862.2023.2205540"},{"key":"5033_CR33","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3109\/10837450.2013.775154","volume":"19","author":"HL Ohrem","year":"2014","unstructured":"Ohrem HL, Schornick E, Kalivoda A, Ognibene R. Why is mannitol becoming more and more popular as a pharmaceutical excipient in solid dosage forms? Pharm Dev Technol. 2014;19:257\u201362.","journal-title":"Pharm Dev Technol"},{"key":"5033_CR34","first-page":"1693","volume":"19","author":"S Hashemian","year":"2023","unstructured":"Hashemian S, Shojaei M, Radbakhsh S, Ashari S, Riahi MM, Amiri ZS, et al. The effects of oral trehalose on glycaemia, inflammation, and quality of life in patients with type 2 diabetes: a pilot randomized controlled trial. Arch Med Sci. 2023;19:1693\u2013700.","journal-title":"Arch Med Sci"},{"key":"5033_CR35","doi-asserted-by":"publisher","first-page":"716126","DOI":"10.3389\/fneur.2021.716126","volume":"12","author":"E Linetsky","year":"2022","unstructured":"Linetsky E, Abd Elhadi S, Bauer M, Gallant A, Namnah M, Weiss S, et al. Safety and tolerability, dose-escalating, double-blind trial of oral mannitol in parkinson\u2019s disease. Front Neurol. 2022;12:716126.","journal-title":"Front Neurol"},{"key":"5033_CR36","unstructured":"Chinese Pharmacopoeia Commission. Pharmacopoeia of the People\u2019s Republic of China: Volume IV. 2025 ed. Beijing: China Medical Science Press; 2025. p. 0103."},{"key":"5033_CR37","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.7150\/thno.30030","volume":"9","author":"J Abello","year":"2019","unstructured":"Abello J, Nguyen TDT, Marasini R, Aryal S, Weiss ML. Biodistribution of gadolinium-and near infrared-labeled human umbilical cord mesenchymal stromal cell-derived exosomes in tumor bearing mice. Theranostics. 2019;9:2325\u201345.","journal-title":"Theranostics"},{"key":"5033_CR38","doi-asserted-by":"publisher","first-page":"11312","DOI":"10.3390\/ijms231911312","volume":"23","author":"AM Aimaletdinov","year":"2022","unstructured":"Aimaletdinov AM, Gomzikova MO. Tracking of extracellular vesicles\u2019 biodistribution: new methods and approaches. Int J Mol Sci. 2022;23:11312.","journal-title":"Int J Mol Sci"},{"key":"5033_CR39","first-page":"1055","volume":"33","author":"C Grange","year":"2014","unstructured":"Grange C, Tapparo M, Bruno S, Chatterjee D, Quesenberry PJ, Tetta C, et al. Biodistribution of mesenchymal stem cell-derived extracellular vesicles in a model of acute kidney injury monitored by optical imaging. Int J Mol Sci. 2014;33:1055\u201363.","journal-title":"Int J Mol Sci"},{"key":"5033_CR40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","volume":"13","author":"HSP De Souza","year":"2016","unstructured":"De Souza HSP, Fiocchi C. Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol. 2016;13:13\u201327.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5033_CR41","doi-asserted-by":"publisher","first-page":"598322","DOI":"10.3389\/fimmu.2020.598322","volume":"11","author":"J Tian","year":"2020","unstructured":"Tian J, Zhu Q, Zhang Y, Bian Q, Hong Y, Shen Z, et al. Olfactory ecto-mesenchymal stem cell-derived exosomes ameliorate experimental colitis via modulating Th1\/Th17 and Treg cell responses. Front Immunol. 2020;11:598322.","journal-title":"Front Immunol"},{"key":"5033_CR42","doi-asserted-by":"publisher","first-page":"5799","DOI":"10.62347\/WLNC8175","volume":"17","author":"J Mai","year":"2025","unstructured":"Mai J, Ke Y, Yao Y. Distinct roles of extracellular vesicles derived from various mesenchymal stem cell sources in bone regeneration: a systematic review and meta-analysis. Am J Transl Res. 2025;17:5799\u2013813.","journal-title":"Am J Transl Res"},{"key":"5033_CR43","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3390\/cells8050467","volume":"8","author":"CR Harrell","year":"2019","unstructured":"Harrell CR, Fellabaum C, Jovicic N, Djonov V, Arsenijevic N, Volarevic V. Molecular mechanisms responsible for therapeutic potential of mesenchymal stem cell-derived secretome. Cells. 2019;8:467.","journal-title":"Cells"},{"key":"5033_CR44","doi-asserted-by":"publisher","first-page":"1509418","DOI":"10.3389\/fphar.2025.1509418","volume":"16","author":"Y Song","year":"2025","unstructured":"Song Y, Liang F, Tian W, Rayhill E, Ye L, Tian X. Optimizing therapeutic outcomes: preconditioning strategies for MSC-derived extracellular vesicles. Front Pharmacol. 2025;16:1509418.","journal-title":"Front Pharmacol"},{"key":"5033_CR45","doi-asserted-by":"publisher","first-page":"7953","DOI":"10.2147\/IJN.S525394","volume":"20","author":"T Wu","year":"2025","unstructured":"Wu T, Liu Y, Wang S, Shi C. MSC-derived extracellular vesicles: Roles and molecular mechanisms for tissue repair. Int J Nanomed. 2025;20:7953\u201374.","journal-title":"Int J Nanomed"},{"key":"5033_CR46","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s11626-024-00910-6","volume":"60","author":"D Zhao","year":"2024","unstructured":"Zhao D, Ji H, Zhao H, Xu Y, He A, He Y. BMSC-derived exosomes regulate the Treg\/Th17 balance through the miR-21-5p\/TLR4\/MyD88\/NF-\u03baB pathway to alleviate dry eye symptoms in mice. Vitro Cell Dev Biol-Anim. 2024;60:644\u201356.","journal-title":"Vitro Cell Dev Biol-Anim"},{"key":"5033_CR47","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.2147\/IJN.S402179","volume":"18","author":"X Liang","year":"2023","unstructured":"Liang X, Li C, Song J, Liu A, Wang C, Wang W, et al. HucMSC-Exo promote mucosal healing in experimental colitis by accelerating intestinal stem cells and epithelium regeneration via Wnt signaling pathway. Int J Nanomed. 2023;18:2799\u2013818.","journal-title":"Int J Nanomed"},{"key":"5033_CR48","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3390\/pharmaceutics15020558","volume":"15","author":"F Draguet","year":"2023","unstructured":"Draguet F, Bouland C, Dubois N, Bron D, Meuleman N, Stamatopoulos B, et al. Potential of mesenchymal stromal cell-derived extracellular vesicles as natural nanocarriers: concise review. Pharmaceutics. 2023;15:558.","journal-title":"Pharmaceutics"},{"key":"5033_CR49","doi-asserted-by":"publisher","first-page":"9986368","DOI":"10.1155\/sci\/9986368","volume":"2025","author":"CC Wang","year":"2025","unstructured":"Wang CC, Hu XM, Liu Y, Xiao Y, Jiang P, Lin YJ, et al. Immunological safety evaluation of exosomes derived from human umbilical cord mesenchymal stem cells in mice. Stem Cells Int. 2025;2025:9986368.","journal-title":"Stem Cells Int"},{"key":"5033_CR50","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.2147\/IJN.S454438","volume":"19","author":"XM Hu","year":"2024","unstructured":"Hu XM, Wang CC, Xiao Y, Liu Y, Huang HR, Jiang P, et al. Non-clinical safety evaluation of exosomes derived from human umbilical cord mesenchymal stem cells in cynomolgus monkeys. Int J Nanomed. 2024;19:4923\u201339.","journal-title":"Int J Nanomed"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-05033-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05033-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05033-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:03:34Z","timestamp":1781136214000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-05033-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,26]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5033"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-05033-1","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,26]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human participants and animals were carried out in full compliance with established ethical standards. The protocol for the collection of human samples was reviewed and approved by the Medical Ethics Committee of Yantai Yuhuangding Hospital (Approval No. 2021003) on November 19, 2021. The approved study, titled \u201cCollection of Human Umbilical Cord Tissue for the Implementation of Registered Stem Cell Clinical Research Projects,\u201d included the acquisition of umbilical cord tissue from three healthy donors. Written informed consent was obtained from each donor or from legally authorized representatives before participation. The animal studies were reviewed and approved by the Animal Research Ethics Committee of Xiamen University (Approval No. XMYY-2025KYSB112) on March 3, 2025. The approved project, entitled \u201cMechanisms of the IOD\u2013Intestinal Microbiota\u2013AhR Axis in Regulating Tryptophan Metabolism in Inflammatory Bowel Disease,\u201d was conducted in accordance with all applicable institutional and national guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"213"}}